ENDOLOGIX INC /DE/ Business Development
ENDOLOGIX INC /DE/ reported Business Development of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessDevelopment · last filed 2017-03-01
- ENDOLOGIX INC /DE/ business development for the quarter ending 2015-03-31 was $113.00K, a 16.49% increase year-over-year.
- ENDOLOGIX INC /DE/ business development for the quarter ending 2014-12-31 was -$45.00K, a 105.98% decline year-over-year.
- ENDOLOGIX INC /DE/ business development for the quarter ending 2014-09-30 was $105.00K.
- ENDOLOGIX INC /DE/ business development for the quarter ending 2014-06-30 was $101.00K.
- ENDOLOGIX INC /DE/ business development for fiscal 2016 was $0.00.
- ENDOLOGIX INC /DE/ business development for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- ENDOLOGIX INC /DE/ business development for fiscal 2014 was $258.00K, a 65.69% decline from fiscal 2013.
- ENDOLOGIX INC /DE/ business development for fiscal 2013 was $752.00K.
| Period end | Business Development 3 month | Business Development 3 month as first filed | Business Development 6 month | Business Development 9 month | Business Development 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-01 | ||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 | ||||
| 2015-03-31 | $113.00K 10-Q · filed 2015-04-29 | $68.00K derived: sum of 2 quarters · filed 2017-03-01 | $173.00K derived: sum of 3 quarters · filed 2017-03-01 | $274.00K derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $60.00K derived: sum of 2 quarters · filed 2017-03-01 | $161.00K derived: sum of 3 quarters · filed 2017-03-01 | $258.00K 10-K · filed 2017-03-01 | |
| 2014-09-30 | $105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $206.00K derived: sum of 2 quarters · filed 2014-11-04 | $303.00K 10-Q · filed 2014-11-04 | $1.05M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $198.00K 10-Q · filed 2014-07-31 | $950.00K derived: sum of 3 quarters · filed 2016-02-29 | $950.00K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $97.00K 10-Q · filed 2015-04-29 | $800.00K 10-Q · filed 2014-05-02 | $849.00K derived: sum of 2 quarters · filed 2016-02-29 | $849.00K derived: sum of 3 quarters · filed 2016-02-29 | $849.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $752.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $752.00K derived: sum of 2 quarters · filed 2016-02-29 | $752.00K derived: sum of 3 quarters · filed 2016-02-29 | $752.00K 10-K · filed 2016-02-29 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $0.00 derived: sum of 2 quarters · filed 2014-11-04 | $0.00 10-Q · filed 2014-11-04 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $0.00 10-Q · filed 2014-07-31 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-02 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 | ||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-03 |